Get startedLog in
    Picture of CK Life Sciences Intl (Holdings) logo

    775 — CK Life Sciences Intl (Holdings) Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    Consumer DefensivesSpeculativeMid CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for CK Life Sciences Intl (Holdings), fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line23820568.6-91.5-18
    Depreciation
    Amortisation
    Non-Cash Items98.597.220925053.7
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-160-1692.84-49.7-94
    Change in Accounts Receivable
    Change in Inventories
    Change in Payable / Accrued Expenses
    Other Operating Cash Flow
    Cash from Operating Activities424364514354187
    Capital Expenditures-217-217-292-199-248
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-40.6195224103-98.6
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-258-22.1-68-96.6-347
    Financing Cash Flow Items-98.1-163-321-335-264
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-220-515-478-342193
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-68.2-199-27.6-11049.1